Forrest Jellison

Papers

Total Citations

H-Index

About

Forrest Jellison has made pioneering contributions to urologic oncology, particularly in expanding the boundaries of robot-assisted surgery for complex patient populations. His research focuses on the application of minimally invasive techniques—specifically robot-assisted laparoscopic radical prostatectomy (RARP)—in patients traditionally considered high-risk or ineligible for surgery. Jellison’s landmark 2011 study on RARP in renal transplant recipients (31 citations) demonstrated that prior transplantation is not a contraindication to safe, effective prostate cancer surgery, offering a critical treatment pathway for this underserved group. In a companion study (6 citations), he showed that patients with end-stage renal disease—who face elevated surgical risks due to multiple comorbidities—can also be viable candidates for RARP, challenging prevailing clinical dogma. These works have influenced surgical decision-making and expanded access to curative therapy. Jellison’s research underscores a commitment to evidence-based innovation in surgical oncology, providing urologists with data to support aggressive treatment in medically complex patients. His contributions remain a reference point for surgeons navigating prostate cancer management in transplant and dialysis populations.